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Abstract
Gliomas are the most common primary brain tumors and yet almost incurable due mainly to their great invasion capability.
This represents a challenge to present clinical oncology. Here, we introduce a mathematical model aiming to improve tumor
spreading capability definition. The model consists in a time dependent reaction-diffusion equation in a three-dimensional
spatial domain that distinguishes between different brain topological structures. The model uses a series of digitized images
from brain slices covering the whole human brain. The Talairach atlas included in the model describes brain structures at
different levels. Also, the inclusion of the Brodmann areas allows prediction of the brain functions affected during tumor
evolution and the estimation of correlated symptoms. The model is solved numerically using patient-specific
parametrization and finite differences. Simulations consider an initial state with cellular proliferation alone (benign tumor),
and an advanced state when infiltration starts (malign tumor). Survival time is estimated on the basis of tumor size and
location. The model is used to predict tumor evolution in two clinical cases. In the first case, predictions show that real
infiltrative areas are underestimated by current diagnostic imaging. In the second case, tumor spreading predictions were
shown to be more accurate than those derived from previous models in the literature. Our results suggest that the inclusion
of differential migration in glioma growth models constitutes another step towards a better prediction of tumor infiltration
at the moment of surgical or radiosurgical target definition. Also, the addition of physiological/psychological considerations
to classical anatomical models will provide a better and integral understanding of the patient disease at the moment of
deciding therapeutic options, taking into account not only survival but also life quality.
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Introduction
Gliomas are a disparate group of primary brain tumors that
share the ability of penetrating diffusely throughout the brain,
though rarely metastasize outside the central nervous system [1,2].
The vast majority of gliomas are from the astrocyte (astrocytomas)
or the oligodendrocyte (oligodendrogliomas) lineage, or a mixture
of both (oligoastrocytomas). Among them, the glioblastoma (grade
IV astrocytoma) is, after the non-malignant meningioma, the most
frequent type of primary brain tumor and that with worse
prognosis [3]. Gliomas usually evolve from lower (neoplasic) to
higher (anaplastic) grades with time, possessing four grades (I, II,
III and IV) for astrocytomas and two grades (II and III) for
oligodendrogliomas and oligoastrocytomas. Most glioblastomas,
nevertheless, occur ‘de novo’ (primary glioblastoma) without
a previous stage of low grade astrocytoma. Although the ‘apex
cell’ (cell of origin) of gliomas is nowadays a subject of research,
many support the hypothesis that the majority of gliomas are
derived from a ‘glioma stem cell’: the malignization of a neuroglial
stem cell or a glial progenitor, rather than the de-differentiation of
a mature glial cell [4,5,6,7].
Despite all modern therapies (surgery combined with chemo
and radiotherapy), glioblastoma has a life expectancy, after
diagnosis, of only around 14 months. This constitutes a real
challenge for present day oncology. Molecular genetics revealed
that glioblastomas are a group of heterogeneous diseases with
common histological features but multiple sets of genetic
mutations and epigenetic deregulations that make them have
different prognosis and therapeutic responses [8,9]. This somehow
explains why there are reports of patients with glioblastoma
outliving up to 10 years and others dying within 2–3 months [10].
In fact, the wide infiltrative area characteristic of gliomas is known
to be underestimated by imaging technology of standard use at
present: computed tomography (CT) and magnetic resonance
imaging (MRI). Surely, this is one of the main reasons of tumor
recurrence after surgery.
There has been a great controversy in the last decade about the
adequate level of resection in glioma treatment because of issues
broughtupagainstthedesignofearlierstudies[11,12].Nevertheless
new reports seem to agree with the idea that the extent of resection
influences the patient’s outcome [13]. In high grade gliomas, gross
totaltumorresectionisassociatedwithlongersurvivalanditisadvised
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lowas78%alsocorrespondtoasurvivaladvantage[15].Evenolder
patients can benefit from maximum treatment procedures as they
tolerate aggressive surgery without increased surgery-related mor-
bidity [16,17]. On the other hand, a study that discriminated high
grade astrocytomasfromhighgradeoligodendrogliomas foundthat
completeresectionsignificantlyincreasedoverallsurvivalonlyinthe
former [18]. In relation to low grade gliomas, available data in
literature also argue in favor of achieving maximal resection of the
tumor for improving survival and delaying tumor progression in
hemispheric gliomas, but also in those limited to certain specific
subregions [19,20]. There are even new approaches that propose
‘‘supramaximal’’ or ‘‘supratotal’’ resections of low grade tumors to
remove as much tumor cells as possible and delay the anaplastic
transformation [21,22].
Biomathematical models able to accurately predict the evolu-
tion of the tumor-mass and infiltrative area may also be of great
help when looking for better survival outcomes. Integrative
mathematical oncology, a new discipline involved in the de-
velopment of mathematical models of tumorigenesis, validated by
experimental and clinical observations and aimed to reconcile
molecular reductionistic with quantitative holistic approaches, has
a potential useful role in this type of complex diseases [23]. Models
that include tumor evolution in ‘virtual patients’ may result in
more realistic predictions helping clinicians to make the best
treatment choice, particularly when these models are made
patient-specific by using parameter values derived from a given
patient. Consequently, mathematical models of glioma evolution
in humans have been developed, based on cell proliferation and
invasion, and aimed at a better prediction of the real tumor
infiltrative area and tumor response after surgery, chemo or
radiotherapy [24,25,26]. Recently, this class of models include the
influence of micro-environmental conditions such as hypoxia,
necrosis and angiogenesis [27,28].
Here, we included different brain topological structures in
a patient-specific 3D model of glioma growth based on the
proliferation/migration basic design with main coefficients derived
from real data. The model allows the spatial correction of the
migration coefficient (and consequently the infiltrative area) in
correspondencewithdifferentbrainzonesandalsothecorrectionof
theestimatedsurvivaltimebasedontumorlocation.Theseinclusions
havethefinalaimofhelpinginthedeterminationofpotentialtargets
for surgery, radiosurgery and/or stereotaxic radiotherapy. Finally,
theinclusionoftheBrodmannareasallowsthepredictionofthebrain
functions that are being affected as the tumor evolves, offering the
possibility of predicting or estimating correlated symptoms. This
could be of great value in the estimation of the consequences of
whether letting the tumor grow or carrying out neurosurgery. The
addition of physiological/psychological considerations to the pre-
vious anatomical glioma growth model will surely provide a better
and integral understanding of the patient disease at the moment of
deciding therapeutic options, taking into account not only survival
but alsolife quality.
Methods
The mathematical model consists in a reaction-diffusion partial
differential equation (PDE) describing the growth and invasiveness
of a glioma inside a human brain (partially based on a model
presented in Swanson [29]). It may be written as:
Lc
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~rc(1{
c
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where c is the concentration of tumor cells in a given node
(cells=mm3), t the time (d), r the net proliferation rate of tumor
cells (cells=d), cm the tumor-cell carrying capacity of the system
(cells=mm3) and D the diffusion rate (mm2=d) of tumor cells. In
the right hand side, the first and second terms represent
proliferation and migration, respectively. The proliferation term
describes the tumor mass growth by a logistic law that depends on
a net proliferation rate (cell proliferation rate minus cell death
rate). The migration term describes the tumor infiltration or
invasion through peripheral normal brain tissue by the Fick’s
diffusion law, assuming that cell migration has a diffusive behavior.
This term is dependent on a diffusion rate that is assimilated to
a cell migration rate.
The tumor evolves, from an initial unique tumor cell, through
a 3D human brain atlas developed by the McConnell Brain
Imaging Center from the Neurological Institute of Montreal
(www.bic.mni.mcgill.ca/brainweb, [30,31]). This atlas is based on
a simulated brain database (BrainWeb) with a series of digitalized
MRI images of human brain slices that cover the whole human 3D
brain with a spatial resolution of 1 mm3. It includes the
intracranial distribution of the different component tissues (white
and gray matter, connective tissue, vessels, cerebrospinal fluid,
dura mater, skull, marrow, muscle, fat and skin). A second atlas
discriminating brain structures at different levels (hemispheres,
lobes, gyrus, tissues and cell types) was superimposed to it. The
Talairach Daemon database (www.talairach.org, [32,33]) was
developed by the Research Imaging Center of the University of
Texas Health Science Center San Antonio (UTHSCSA) and it is
based on the brain labels present in the Talairach atlas [34]. As it
also considers the Brodmann areas (cortical areas that have been
related to specific functionalities [35]), it offers the possibility of
estimating the main neurological functions that may be affected
during tumor evolution. The digitalized Talairach atlas, having
a spatial resolution of 5 mm, was adapted to satisfy coordinate-
accordance with the Brainweb atlas.
The simulated tumor presents an initial state only with cellular
proliferation (benign tumor) and a subsequent advanced state
where cellular infiltration starts (malignization of the tumor). This
infiltration is structural-dependant, meaning that the net diffusion
rate is variable depending on the brain topological structure
present in each spatial point of the brain. It is known that glioma
cells, like neuroglial stem or glial progenitor cells, migrate mainly
along the white matter tracks tending to avoid neuronal
accumulations like deep brain nuclei [36]. Indeed, recent data
suggest that glioma cell infiltration recreates key aspects of glial
progenitor migration [37]. So, after extracting the basal diffusion
coefficient from patient’s MRI images, we considered it to be
about five times larger for white matter than for gray one, as
previously reported [29]. In addition to this, and based on clinical
medical expertise of our own and others, we included a 20% larger
diffusion coefficient inside the corpus callosum and optical track;
and a 20% smaller coefficient inside medulla, brainstem, pons and
midbrain, than in the rest of the white matter. For gray matter, we
included a 20% smaller diffusion coefficient inside basal nucleus
(striatum, globus pallidus, substantia nigra, subthalamic nucleus,
lentiform nucleus, amygdala and claustrum), than in cortex. These
percentages were chosen in order to fit clinical data.
The mathematical model was approximated by finite differ-
ences, using standard relaxation techniques, and implemented in
MATLAB. Simulated 3D tumor images were generated by the
NIFTI package. Although some parameter values were estimated
in accordance to previous bibliography (see table 1 for details), the
main parameters (net proliferation and migration rates) were
derived from the patients under study, thus making the simulation
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mass and infiltrative areas evidenced, respectively, by T1-
gadolinium and T2 MRI brain scans from the patient, as it is
generally accepted. Indeed, the peritumoral edema observed in T2
MRI images is partly due to vasogenic mechanisms but also to
a microscopic extension of sparse tumor cells [38], so we
considered this area as the visible infiltrative area of the tumor.
By analyzing two MRI scans of the patient at different times, with
no therapeutic intervention between them, two approximations
can be applied to estimate D and r. The Fisher’s approximation to
calculate the radial velocity of the tumor mass (v)( mm=d) [39,40]:
v~2
ﬃﬃﬃﬃﬃﬃﬃ
Dr
p
ð2Þ
and [41,25]:
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being Vi and Vt the estimated volumes of the infiltrative area and
the tumor mass, respectively. Radius and areas involved were
calculated from these images using the ImageJ software, and
estimated volumes were derived from them, assuming spherical
shapes. The basal diffusion coefficient D derived from equations 2
and 3 was considered to be Dw or Dg depending on tumor initial
location (in white or gray matter, respectively).
The relation D=r is defined as the invisibility index. As the
infiltrative area in gliomas is known to be more extended than
what it is observed even by the T2 MRI scan (that it is assumed to
loss at least 2% of the real area of tumor invasion [25]), the
invisibility index gives an idea of how dangerous the tumor is and
what are the eventual consequences of a surgery on it. Indeed, in
some cases tumors can be cultured from normal-appearing tissue
4 cm from the edge of glioblastomas [42]. So, the estimation of the
tumor growth and invasion parameters in a patient at a certain
moment is aimed at the generation of a ‘virtual patient’ able to
mimic the evolution of the real disease. Eventually, this may help
the clinician to determine the prognosis at the moment of taking
complex decisions based on risk/benefit relationships.
The simulation indicates the diagnosis time based on the tumor
area detected at the first MRI scan available. As tumor mass
evolves, it also calculates the relative extension of each Brodmann
area (size of tissue affected relative to the total size of that area)
that is being affected. In this kind of prediction of structures or
Brodmann areas affected by tumor growth, tumor infiltration is
not considered (only tumor mass is taken into account). It has been
shown that invasion and spread of low grade tumor cells
throughout large areas of the brain happens very slowly over the
course of years without interrupting normal regional functionality
[1]. The amount of tumor cells in a tissue with detectable altered
signal characteristics (shown by an MRI scan) may be as low as
20% and, with this tissue composition, independent functioning is
still possible. Due to the great plasticity of the brain, even a large
tumor mass invasion with related neuronal damage may not
evidence symptoms. Previous data resulting from Parkinson’s
disease studies report that most patients have lost 60 to 80 percent
or more of the dopamine-producing cells in the substantia nigra by
the time symptoms appear [43]. Therefore, here we assumed that
there is necessary more than a 60% of a given Brodmann area
affected by the tumor mass for related symptoms to become
perceptible.
The relationship between Brodmann areas and related
symptoms can be extracted from the Brodmann’s Interactive
Atlas developed by the Department of Radiology of the Miami
Children’s Hospital (www.fmriconsulting.com/brodmann/index.
html). The inclusion of the Brodmann areas in the model is aimed
to accomplish a prediction of different brain functions that may be
affected as tumor evolves, and not to obtain a diagnosis time based
on the appearance of this type of symptoms. Indeed, first
symptoms that usually leads to a diagnosis are rather nonspecific:
fatigue, sleep disturbance, headache and seizures [10]. Only
a more detailed analysis of cases whose diagnosis is based on
cognitive impairment appearance may be useful for testing this
hypothesis.
The survival time was estimated on the basis of tumor size
and the site where the tumor is located. In this way, we
included in the model a higher death risk as tumor mass
invades areas around the foramen magnum. Previous models
only accounted for the tumor size, but it is known that 73% of
the time, the cause of death in glioma patients is brain
herniation (mainly at the place called ‘foramen magnum’, in the
base of the skull). Herniation puts extreme pressure on local
tissues cutting off the blood supply, inducing comma and
eventually the death of the patient. In the rest of the cases,
death is finally due to pulmonary embolism, infection, bowel
perforation from steroid use or seizures [10].
Results and Discussion
Simulation of Case 1
Case 1 is a 63 years old male patient, under follow up in our
hospital, with a grade IV glioblastoma (determined by
histopathology) in the right temporal lobe. As it can be
observed in figure 1, at the time of diagnosis the tumor is
located very close to the cortex. This corresponds with a higher
probability of seizures, symptom that led this patient to a first
medical consultation. Patient-specific analysis of this glioma
determined that it was characterized by a net proliferation rate
of 0.107 cells/day and a net diffusion (migration) rate of 0.255
mm2=d in white matter. Corresponding tumor mass velocity
and invisibility index were 120.8 mm/year and 2.38 mm2,
respectively. Considering the range of values reported for high
grade gliomas (velocities of 10 to 200 mm/year and invisibility
index of 2 to 20 mm2 [25]), those values meant that this tumor
had a relatively intermediate growth velocity and low invisibility
index. These parameters describe a relatively ‘benign’ tumor in
relation with the glioblastoma spectrum. In correspondence with
Table 1. Main parametric values used in simulations.
Parameter Value Parameter Value
p1 0.107 cells/d p2 0.0107 cells/d
Dw1 0.255 mm
2/d Dw2 0.805 mm
2/d
Dg1 0.051 mm
2/d Dg2 0.161 mm
2/d
ddiag1 18.26 mm ddiag2 16.98 mm
dlet 70 mm Cmass 106 cel/mm
3
Cinv 107 cel/mm
3 Cmax 108 cel/mm
3
p1: net proliferation rate for case 1, p2: idem for case 2, Dw1: net diffusion rate
in white matter for case 1, Dw2: idem for case 2, Dg1: net diffusion rate in gray
matter for case 1, Dg2: idem for case 2, ddiag1: tumor diameter at diagnosis for
case 1: ddiag2: idem for case 2, dlet: lethal tumor diameter [58], Cmass: tumor cell
concentration at the limit of the tumor mass, Cinv: tumor cell concentration that
determines invasion (malignization) of the tumor, Cmax: tumor cell carrying
capacity [26].
doi:10.1371/journal.pone.0039616.t001
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rare case that was left without surgical intervention up to five
months from diagnosis.
Simulation of case 1 in a ‘virtual patient’ began with the
localization of an initial unique tumor cell in the white matter of
the superior temporal gyrus. Malignization of the tumor was
predicted around 152 days (five months) after its onset and
diagnosis after 267 days (nine months). The whole simulation of
this case can be observed in the File Case S1 video submitted as
a supporting information file. Figure 1 shows the real and
simulated tumor at the diagnosis time for different tumor views. In
simulated images (figures 1(d) and 1(e)), the central white area
represents the concentrated tumor mass while the black surround-
ing area indicates tumor infiltration, with low concentration of
tumor cells invading normal brain tissue.
A good correlation between real and simulated radios of the
tumor mass can be observed (8.9 vs. 9.7 mm, respectively). When
the simulated image is generated with the same detection level as
the MRI technique (around 400 cells/mm2 [29]), there is also
a fairly good correlation between real and simulated infiltrative
areas (compare figure 1(c) with 1(d), axial view). Simulated
infiltrative areas detected at 1 cell/mm2, nevertheless, indicate that
they would be underestimated by current diagnostic imaging. This
is something also reported by others [25] and it is related to one of
the main potential clinical utilities of this type of models.
Figure 2 presents the tumor mass and infiltration 20 days
after diagnosis time. At this time, real and simulated tumor
mass radios are 12.1 and 12.2 mm2, respectively. Simulated
infiltrative areas also correlate well with those derived from real
images when generated at the same detection level (see figures 1
and 1, axial view), but a higher level of detection indicates
again that this area may be larger than that evidenced by real
MRI images. These two moments (diagnosis time and 20 days
after) were used to estimate the main parameters of the model
Figure 1. Case 1 at diagnosis. a) Coronal, b) Sagital and c) Axial view of T2 MRI real images of the tumor. d) and e) Corresponding simulated MRI
images generated at a detection level of d) 400 cells/mm2 and e) 1 cell/mm2. In simulations, white areas represent the tumor mass and black ones,
tumor infiltration.
doi:10.1371/journal.pone.0039616.g001
Modeling Glioma Growth Based on Brain Structures
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39616(net proliferation and diffusion rates) in a patient-specific way.
Tumor evolution to the next time stage (40 days after diagnosis)
was then predicted by the model.
Figure 3 shows the predicted tumor-mass and infiltrative areas
40 days after diagnosis, over different slices from the axial plane,
given a better overview of the 3D tumor evolution. A good
correspondence can be observed between real and simulated
images generated at a detection level of 400 cells/mm
2 (compare
first with second row of images). Here, tumor mass radii are 14.8
and 15.8 mm, respectively. Again, a higher detection level of 1
cell/mm2 indicates larger invasion than that observed by MRI real
images (third row). These results indicate a fairly good prediction
accomplished by the numerical model.
Figure 4 superimposes the predicted tumor mass at different
times upon the Talairach atlas, indicating the main brain
structures that are being affected by tumor evolution. At diagnosis
time (270 days from tumor onset, figure 3), tumor mass affects
8.2% of the Brodmann area 41 and 12.6% of the Brodmann area
42 (references 2 and 3, respectively). These areas belong to the
primary auditory cortex (Heschl’s gyrus). Related main functions
are basic processing of auditory stimuli (speech and non-speech)
[44,45] and processing of sound intensity [46,47].
50 days after diagnosis (320 days from tumor onset, figure 4(b)),
the tumor mass invades great part of transverse and superior gyrus
of the temporal lobe (references 1 and 6, respectively) and 10.9%
of the Brodmann area 22 (reference 4). If the dominant cerebral
hemisphere were the right one, this area would be part of the
Wernicke’s area, fully related to auditory comprehension of
language [48]. If it was not, as in the majority of cases, this area
would have also roles related with receptive language but in
a subordinated way, leading to a bilateral dissociation design [49].
This seems to be the case with functions related to lexical
Figure 2. Case 1, 20 days after diagnosis. a) Axial view of a T2 MRI real image of the tumor. b) and c) Simulated MRI images of central slices of
the tumor generated at a detection level of b) 400 cells/mm2 and c) 1 cell/mm2. In simulations, white areas represent the tumor mass and black ones,
tumor infiltration.
doi:10.1371/journal.pone.0039616.g002
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Corresponding simulated slices generated at a detection level of 400 cells/mm2. g), h), and i): Corresponding simulated slices generated at a detection
level of 1 cell/mm2. In simulations, white areas represent the tumor mass and black ones, tumor infiltration.
doi:10.1371/journal.pone.0039616.g003
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function as processors of dominant and subordinated meanings
of ambiguous words, respectively.
100 days after diagnosis (370 days from tumor onset, figure 4(c)),
the tumor has expanded to the pre-central gyrus of the frontal lobe
(10) and up to the right lateral ventricle (7). It also affected 21.4%
Figure 4. Case 1, predicted Talairach structures affected by the tumor mass during its development. a) At diagnosis, b) 50 days after
diagnosis, c) 100 days after diagnosis and d) 140 days after diagnosis (time of death). Tumor detection level at 106 cells/mm2. Infiltrative areas have
been omitted. Numbers indicate brain structures: 1: transverse gyrus, temporal lobe; 2: Brodmann area 41; 3: Brodmann area 42; 4: Brodmann areas
22; 5: Brodmann area 39; 6: superior gyrus, temporal lobe; 7: lateral ventricle; 8: Brodmann area 13; 9: Brodmann area 43; 10: precentral gyrus, frontal
lobe; 11: insula; 12: lentiform nucleus; 13: thalamus.
doi:10.1371/journal.pone.0039616.g004
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and 3.3% of the Brodmann area 39 (5). Brodmann area 43 is
associated with some motor responses to vibrotactile digit
stimulation [50] and to spoken language [51]. Brodmann area
13 belongs to the insular cortex, that is reported to participate in
somatosensory [52], olfaction and taste [53], and verbal memory
functions [54], among others. Finally, Brodmann area 39 is also
part of the Wernicke’s area or its contralateral homologous. In the
right hemisphere, it is generally associated to visuospatial
processing [55] and music reading [56]. Figure 4(d) predicts that,
at the time of death (survival time of 140 days after diagnosis or
410 days from tumor onset), the tumor mass has extended through
the insula (11), lentiform nucleus (12) and thalamus (13).
Figure 5 presents tumor status at the predicted time of death.
The estimated tumor mass diameter (assuming an spherical shape)
at this moment is 62.9 mm, a value slightly smaller than the lethal
size parameter used (70 mm, see table 1). This might be attributed
to the corrections added to the model in relation with tumor
location. Indeed, at this time the tumor mass edge reaches the
‘foramen magnum’, as is evidenced by the Talairach atlas in
figure 5(b). This means that herniation, and consequently death,
could be imminent.
Simulation of Case 2
Case 2 is a 32 years old male with a histopathology of anaplastic
oligodendroglioma (grade III) reported in previous literature [57].
The whole simulation of this case can be observed in the File Case
S2 video submitted as a supporting information file. Figure 6
compares simulations of this case at different times made with two
distinct mathematical models: left column corresponds to simula-
tions obtained with the present model, right column corresponds
to simulations derived from our implementation of a model
previously described in the literature [29] (this model does not
include differential migration based on topological brain struc-
tures). This figure should be compared with figure 1a and 1c from
[57] that shows the real MRI images from this patient. Real tumor
dimensions correspond well with those predicted by the present
model. At diagnosis, real and simulated tumor mass radii are 8.9
and 8.7 mm; while tumor infiltration radii are 28.4 and 28.9 mm,
respectively (compare figure 1a from [57] with axial view from
figure 6(a)). Eighteen days after diagnosis, real and simulated
tumor mass radii are 11.4 and 10.6 mm; and tumor infiltration
radii are 33.1 and 31.2 mm, respectively (compare figure 1c from
[57] with axial view from figure 6(c)). Simulations made with
a previous model (figures 6(b) and 6(d)) also reach tumor
dimensions similar to real ones.
However, if we analyze tumor spreading the situation is
different. Our model seems to be more accurate regarding tumor
spreading than previous ones and these differences between
models become significant 18 days after diagnosis. Real images
show that tumor invasion through the corpus callosum is
significantly augmented at that time (figures 1c and 1d from
[57]). They also evidence a mass-effect that compresses the lateral
ventricles. Although this kind of mathematical models do not
include the mass-effect, this type of spreading through the corpus
callosum can be observed in simulations made with our model (see
axial view form figure 6(c)) but not in those derived from previous
ones (axial view from figure 6(d)).
This consideration is extremely important, as its consequences
worsen with time: differences between both models become more
evident 100 days after diagnosis, as it can be evidenced in
figures 6(e) and 6(f). At this time point, simulations made with the
present model predicts a larger spreading of the tumor through the
corpus callosum with tumor cells reaching the contralateral
hemisphere and anterior zones of the brain. Simulations with
previous models, on the contrary, do not evidence this type of
spreading. Though this time stage does not have real images to
correlate with, it evidences the natural evolution of the previous
tumor status.
Conclusions
Despite all modern therapies, gliomas continue to be a challenge
for present oncology, mainly due to their great invasion capability.
This makes surgical or radiosurgical ‘security margins’ often
Figure 5. Case 1, predicted tumor evolution at death. a) Simulated MRI images of central slices of the tumor generated at a detection level of 1
cell/mm2. White areas represent the tumor mass and black ones, tumor infiltration. b) Simulated tumor mass near the area of the ‘foramen magnum’
evidenced by the Talairach atlas. Here, infiltrative areas have been omitted.
doi:10.1371/journal.pone.0039616.g005
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eventually are the cause of treatment failure. The development
of more realistic mathematical models able to accurately predict
the extent and distribution of tumor cell infiltration through
normal brain tissue would be an additional predictive tool of
clinical utility.
In this paper we aimed to make a contribution to present
models of glioma growth in humans through the introduction of
brain topological structures into a 3D patient-specific mathemat-
ical model based on cell proliferation and invasion through normal
tissue. This allows the correction of cell infiltration margins, life
expectancy and, with the inclusion of Brodmann areas, the
eventual prediction of brain functions that could be affected by the
tumor mass or by an eventual therapeutic intervention.
The model was applied to two clinical cases, making accurate
predictions based on parameters obtained from MRI images of the
patients involved. Patient-specificity is a very important charac-
teristic of present models of glioma growth, as parameter values
extracted from average population are not valid due to the great
variety of glioma subclasses. The analysis of tumor spreading
predictions made by our present model shows, in the second
clinical case, that it is able to accomplish a better prediction of the
real tumor state than that achieved by previous models present in
literature.
This type of models could guide the surgeon to better decisions
based on information about how the tumor will evolve in terms of
tumor mass, infiltrative areas and their relative relevance for
survival or neurological functions. For instance, in one case a more
extensive resection would be justified if the tumor has infiltrated an
area not compromised with vital functions or not essential in terms
of life quality. In another case, on the contrary, it would not worth
a larger resection than the tumor mass due to the great extension
of the infiltration and/or the relevance of the brain areas involved.
Finally, a case with a tumor mass extending to vital structures
would justify a more aggressive intervention before it reaches
them. Although we checked our model with two high grade
gliomas, it can also be applied to low grade ones, as they are also
already infiltrating at first diagnosis. The inclusion of differential
migration based on topological brain structures in glioma growth
is another step towards a better prediction of the extension and
shape of tumor infiltration at the moment of surgical or
radiosurgical target definition.
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